Administrative prescription review procedures and use of atypical antipsychotic medications in the department of veterans affairs

Mental Health Services Research

Volumn 5, Issue 3, 2003, Pages 149-153

  Rosenheck, Robert ^b   Leslie, Douglas ^a  

^a Education and Clinical Center   (United States)

^b Northeast Program Evaluation Center   (United States)

Author keywords

Antipsychotic medication cost containment; Psychopharmacology; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; GOVERNMENT; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PSYCHIATRIST; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TREATMENT INDICATION;

ANTIPSYCHOTIC AGENTS; COST CONTROL; DATA COLLECTION; DECISION MAKING; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 0042697151     PISSN: 15223434     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024491301954     Document Type: Review

References (7)

1. Essock, S. M., Frisman, L. K., Covell, N., & Hargreaves, W. A. (2000). Cost-effectiveness of clozpaine compared with conventional antipsychoticmedication for patients in state hospitals. Archives of General Psychiatry, 57(10), 987-994.
2. Leslie, D., & Rosenheck, R. A. (2001). The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia. Journal of Nervous and Mental Disease 189(6):377-383.
3. Leslie, D., & Rosenheck, R. A. (2002). Third annual report on pharmacotherapy of schizophrenia in the Department of Veterans Affairs (2002). West Haven, CT: Northeast Program Evaluation Center.
4. Rosenheck, R. A., Cramer, J., Xu, W., Grabowski, J., Douyon, R., Thomas, J., Henderson, W. et al. (1998). Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Health Services Research 33(5):1235-1259.
5. Rosenheck, R. A., Cramer, J., Xu, W., Thomas, J., Henderson, W., & Frisman, L. K. et al. (1997). A comparison of clozapine and haloperidol in the treatment of hospitalized patients with refractory schizophrenia. New England Journal of Medicine 337: 809-815 (For the Department of Veterans Affairs Cooperative Study Group on clozapine in refractory schizophrenia.)
6. Rosenheck, R. A., Leslie, D. L., & Sernyak, M. E. (2001). From clinical trials to real-world practice: Use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Medical Care, 39(3):302-308.
7. U.S. General Accounting Office. (2002 April). VA health care. Implementation of prescribing guideline for atypical antipsychotic drugs generally sound. (GAO 02-579). Washington, DC.